The global peripheral artery disease market size reached USD 4.9 Billion in 2024. Looking forward, the research expects the market to reach USD 7.7 Billion by 2033, exhibiting a growth rate (CAGR) of 4.98% during 2025-2033. The rising number of geriatric populations, various technological innovations in the diagnosis and treatment, increasing adoption of home care settings, improvement in healthcare infrastructure, and changing living standards of individuals are propelling the market growth.
Peripheral artery disease (PAD) is a cardiovascular disorder wherein constricted arteries restrict blood flow to the limbs. It results in hair loss, leg numbness, feet or toe sores, painful cramps in hips and thighs, coldness and weak pulse in legs, and erectile dysfunction among men. It is caused when a plaque, also known as atherosclerosis, develops in leg arteries that carry oxygen and nutrient-rich blood from the heart to the arms and legs.
It is diagnosed using the ankle-brachial index, ultrasound scan, angiography, blood tests, doppler and ultrasound (duplex) imaging, computed tomographic angiography (CT), and magnetic resonance angiography (MRA). The peripheral artery disease market overview indicates an increasing demand for advanced diagnostic and treatment options, as rising awareness and the growing prevalence of risk factors such as diabetes and hypertension are pushing for more effective solutions in managing and treating PAD.
Furthermore, these less invasive procedures preserve normal vascular anatomy while improving long-term patency rates, leading to better overall outcomes. The peripheral artery disease market trends show a shift towards more advanced, patient-friendly treatment options, with increasing demand for innovative devices that enable better clinical results and improved quality of life for PAD patients.
Peripheral artery disease (PAD) is a cardiovascular disorder wherein constricted arteries restrict blood flow to the limbs. It results in hair loss, leg numbness, feet or toe sores, painful cramps in hips and thighs, coldness and weak pulse in legs, and erectile dysfunction among men. It is caused when a plaque, also known as atherosclerosis, develops in leg arteries that carry oxygen and nutrient-rich blood from the heart to the arms and legs.
It is diagnosed using the ankle-brachial index, ultrasound scan, angiography, blood tests, doppler and ultrasound (duplex) imaging, computed tomographic angiography (CT), and magnetic resonance angiography (MRA). The peripheral artery disease market overview indicates an increasing demand for advanced diagnostic and treatment options, as rising awareness and the growing prevalence of risk factors such as diabetes and hypertension are pushing for more effective solutions in managing and treating PAD.
Peripheral Artery Disease Market Trends:
Technological Advancements in Minimally Invasive Surgeries
The development of sophisticated catheter-based devices and techniques is revolutionizing vascular interventions, offering less invasive alternatives to traditional open surgeries. These advancements are significantly improving treatment outcomes by reducing patient discomfort, shortening hospital stays, and enabling faster recovery times. New devices, such as advanced angioplasty balloons, drug-coated balloons, atherectomy devices, and specialized stents, are expanding the range of treatment options available for PAD. These innovations offer greater flexibility, deliverability, and efficacy, allowing clinicians to treat complex lesions more effectively.Furthermore, these less invasive procedures preserve normal vascular anatomy while improving long-term patency rates, leading to better overall outcomes. The peripheral artery disease market trends show a shift towards more advanced, patient-friendly treatment options, with increasing demand for innovative devices that enable better clinical results and improved quality of life for PAD patients.
Changing Living Standards of Individuals
People are increasingly suffering from peripheral artery disease (PAD) due to lifestyle-related factors, such as diabetes, obesity, hypertension, and smoking. As global rates of these conditions increase, particularly in regions with aging populations, more individuals are at risk of PAD. Diabetes contributes to atherosclerosis, which narrows arteries and restricts blood flow, leading to PAD. As a result, the demand for diagnostic tools and treatments, such as angioplasty, stenting, and bypass surgery, is rising. Additionally, the global burden of cardiovascular diseases (CVDs) is pushing healthcare systems to focus on early detection and management of PAD.Aging Population
The global aging population across the globe is a crucial factor impelling the market growth. Older adults face a higher risk of developing PAD owing to age-related vascular changes and atherosclerosis. As people age, their arteries naturally lose elasticity, which can result in narrowed or blocked arteries, a hallmark of PAD. This demographic shift drives demand for healthcare services including diagnostics, preventive treatments, and minimally invasive (MI) interventions like angioplasty and stent placement. In line with this, healthcare providers are increasingly focusing on addressing the needs of elderly patients, who often have complex health profiles, which is thereby contributing to the peripheral artery disease market growth.Key Market Segmentation:
The research provides an analysis of the key trends in each segment of the global peripheral artery disease market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on type and end user.Breakup by Type:
- Peripheral Angioplasty Balloons
- Peripheral Stents
- Peripheral Catheters
- Inferior Vena Cava (IVC) Filters
- Plaque Modification Devices
- Hemodynamic Flow Alteration Devices
- Peripheral Accessorie.
Breakup by End User:
- Hospitals
- Specialty Clinics
- Other.
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Afric.
Competitive Landscape:
The peripheral artery disease market research report has also provided a comprehensive analysis of the competitive landscape in the global market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:- Abbott Laboratories
- AngioDynamics
- B. Braun Melsungen AG
- Becton Dickinson and Company
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Cardinal Health Inc.
- Cook Medical LLC
- Koninklijke Philips N.V.
- Medtronic plc
- Terumo Corporatio.
Key Questions Answered in This Report
- How big is the global peripheral artery disease market?
- What is the expected growth rate of the global peripheral artery disease market during 2025-2033?
- What are the key factors driving the global peripheral artery disease market?
- What has been the impact of COVID-19 on the global peripheral artery disease market?
- What is the breakup of the global peripheral artery disease market based on the type?
- What are the key regions in the global peripheral artery disease market?
- Who are the key players/companies in the global peripheral artery disease market?
Table of Contents
1 Preface3 Executive Summary10 Value Chain Analysis12 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Peripheral Artery Disease Market
6 Market Breakup by Type
7 Market Breakup by End User
8 Market Breakup by Region
9 SWOT Analysis
11 Porters Five Forces Analysis
13 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Abbott Laboratories
- AngioDynamics
- B. Braun Melsungen AG
- Becton Dickinson and Company
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Cardinal Health Inc.
- Cook Medical LLC
- Koninklijke Philips N.V.
- Medtronic plc
- Terumo Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 149 |
| Published | June 2025 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 4.9 Billion |
| Forecasted Market Value ( USD | $ 7.7 Billion |
| Compound Annual Growth Rate | 5.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
